Natco Pharma USA LLC
15 drugs in NADAC|15 Generic,0 Brand
Natco Pharma USA LLC lists 15 NDCs in the CMS NADAC file (15 generic, 0 brand), at an average NADAC of $0.31 per unit, with a week-over-week move of -0.4% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
15
15G / 0B
Avg Price / Unit
$0.3084
$0.06 – $0.87
Avg 7d Change
-0.41%
Across 13 drugs with changes
7d Activity
of 15 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Ondansetron market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Serotonin-3 Receptor Antagonist therapeutic class
Review the broader class where Natco Pharma USA LLC has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Natco Pharma USA LLC make?
Natco Pharma USA LLC lists 15 NDCs in the CMS NADAC file — 15 generic and 0 brand products.
What is the average price of Natco Pharma USA LLC drugs?
The average NADAC across Natco Pharma USA LLC's portfolio is $0.3084 per unit, ranging from $0.0582 to $0.8651.
What types of drugs does Natco Pharma USA LLC make?
Natco Pharma USA LLC makes drugs across 3 FDA pharmacologic classes. The most common by NDC count are Serotonin-3 Receptor Antagonist (5), Nitrate Vasodilator (4), Chloride Channel Activator (2).
Has Natco Pharma USA LLC had any drug recalls?
No FDA enforcement recalls are matched to Natco Pharma USA LLC in the openFDA feed.
How has Natco Pharma USA LLC's pricing changed recently?
Over the past 7 days, 5 Natco Pharma USA LLC products rose and 8 fell, with a portfolio-wide average change of -0.4%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ARMODAFINIL 250 MG TABLET Armodafinil | $0.8651 per EA | — |
ARMODAFINIL 200 MG TABLET Armodafinil | $0.8028 per EA | -2.17% |
ARMODAFINIL 150 MG TABLET Armodafinil | $0.7517 per EA | — |
LUBIPROSTONE 24 MCG CAPSULE LUBIPROSTONE | $0.6507 per EA | +4.30% |
LUBIPROSTONE 8 MCG CAPSULE LUBIPROSTONE | $0.5652 per EA | +2.89% |
ARMODAFINIL 50 MG TABLET Armodafinil | $0.3056 per EA | +0.46% |
NITROGLYCERIN 0.4 MG TABLET SL NITROGLYCERIN | $0.1272 per EA | -0.52% |
NITROGLYCERIN 0.6 MG TABLET SL NITROGLYCERIN | $0.0843 per EA | +8.29% |
NITROGLYCERIN 0.4 MG TABLET SL NITROGLYCERIN | $0.0787 per EA | -5.83% |
ONDANSETRON HCL 8 MG TABLET Ondansetron | $0.0781 per EA | -3.83% |
ONDANSETRON HCL 8 MG TABLET Ondansetron | $0.0781 per EA | -3.83% |
NITROGLYCERIN 0.3 MG TABLET SL NITROGLYCERIN | $0.0631 per EA | +2.00% |
ONDANSETRON HCL 4 MG TABLET Ondansetron | $0.0582 per EA | -2.38% |
ONDANSETRON HCL 4 MG TABLET Ondansetron | $0.0582 per EA | -2.38% |
ONDANSETRON HCL 4 MG TABLET Ondansetron | $0.0582 per EA | -2.38% |